Regeneron Pharmaceuticals
REGN
#331
Rank
โ‚ฌ62.89 B
Marketcap
599,94ย โ‚ฌ
Share price
-2.05%
Change (1 day)
12.85%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚ฌ4.39 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ14.91 Billion. In 2025 the company made an earning of โ‚ฌ4.49 Billion, an increase over its 2024 earnings that were of โ‚ฌ4.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ4.39 B-2.15%
2025 โ‚ฌ4.49 B9.43%
2024 โ‚ฌ4.10 B13.83%
2023 โ‚ฌ3.60 B-13.57%
2022 โ‚ฌ4.17 B-47.9%
2021 โ‚ฌ8.01 B144.75%
2020 โ‚ฌ3.27 B56.86%
2019 โ‚ฌ2.08 B-4.87%
2018 โ‚ฌ2.19 B22.86%
2017 โ‚ฌ1.78 B56.3%
2016 โ‚ฌ1.14 B8.55%
2015 โ‚ฌ1.05 B54.53%
2014 โ‚ฌ0.68 B11.14%
2013 โ‚ฌ0.61 B72.13%
2012 โ‚ฌ0.35 B-285.93%
2011 -โ‚ฌ0.2 Billion121.73%
2010 -โ‚ฌ86.38 Million37.18%
2009 -โ‚ฌ62.97 Million-14.6%
2008 -โ‚ฌ73.73 Million-25.02%
2007 -โ‚ฌ98.34 Million6.32%
2006 -โ‚ฌ92.5 Million-186.52%
2005 โ‚ฌ0.10 B2103.7%
2004 โ‚ฌ4.85 M-105.66%
2003 -โ‚ฌ85.73 Million-18.18%
2002 -โ‚ฌ0.11 Billion42.33%
2001 -โ‚ฌ73.62 Million129.35%
2000 -โ‚ฌ32.1 Million51.87%
1999 -โ‚ฌ21.14 Million92.19%
1998 -โ‚ฌ11 Million66.23%
1997 -โ‚ฌ6.62 Million-55.49%
1996 -โ‚ฌ14.87 Million103.53%
1995 -โ‚ฌ7.31 Million-70.89%
1994 -โ‚ฌ25.09 Million-26.08%
1993 -โ‚ฌ33.94 Million114.67%
1992 -โ‚ฌ15.81 Million196.77%
1991 -โ‚ฌ5.33 Million87.88%
1990 -โ‚ฌ2.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.32 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.56 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚ฌ7.80 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.58 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ1.39 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.74 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA